Our Pricing

Understanding Mounjaro Private Prescription Prices in the UK

Published on: June 03, 2026

When comparing mounjaro private prescription prices uk, transparency matters. At Cured Pharmacy, Mounjaro (tirzepatide) KwikPen starts from £124.99, with pricing confirmed upfront before your free online consultation with a UK-registered prescriber. Unlike many providers, we show exact costs before you begin your clinical assessment.

What Affects Mounjaro Private Prescription Prices UK?

Private prescription costs for Mounjaro vary based on three key factors: your prescribed dose strength, treatment duration, and whether the pharmacy includes prescriber fees separately. Mounjaro is available in five dose strengths (2.5mg, 5mg, 7.5mg, 10mg, and 15mg), with patients typically starting at the lowest dose and titrating upward over 16-20 weeks according to MHRA-approved protocols [1].

At Cured Pharmacy, our pricing from £135.00 includes both the medication and your clinical consultation with a UK prescriber—no hidden fees or surprise charges at checkout. Many patients find this transparent approach more cost-effective than providers who separate consultation fees, delivery charges, and medication costs across multiple invoices.

The dose escalation schedule recommended by the MHRA means your monthly cost will increase as your prescriber adjusts your dose upward, assuming you tolerate the medication well and meet clinical criteria for dose advancement [1]. Your UK prescriber will determine the appropriate dose based on your response, side effects, and weight loss progress during follow-up consultations.

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway medications, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors—two natural hormones that regulate appetite, food intake, and glucose metabolism.

In the landmark SURPASS-3 clinical trial, participants taking the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to baseline [1]. The SURMOUNT-1 trial, which specifically examined tirzepatide for weight management in adults without diabetes, showed average reductions of 15.0%, 19.5%, and 20.9% for the 5mg, 10mg, and 15mg doses respectively [2].

These clinical outcomes represent some of the highest weight reductions observed in pharmaceutical trials to date, though individual results vary considerably based on adherence to lifestyle modifications, baseline BMI, and metabolic factors [2]. All patients prescribed Mounjaro should follow a reduced-calorie diet and increased physical activity programme as directed by their healthcare provider.

Who Can Be Prescribed Mounjaro in the UK?

UK prescribers follow MHRA guidance when assessing suitability for Mounjaro. Generally, tirzepatide may be prescribed for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia [3].

Your online consultation at Cured Pharmacy includes a comprehensive medical history review by a UK-registered prescriber who will assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or previous pancreatitis [3]. Mounjaro is not suitable during pregnancy or breastfeeding.

Mounjaro vs Wegovy: Comparing Private Prescription Options

Both Mounjaro and Wegovy are once-weekly injectable medications licensed in the UK for chronic weight management, but they work through different mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist, while Mounjaro's tirzepatide activates both GIP and GLP-1 receptors—a dual-action approach that clinical trials suggest may produce greater weight loss outcomes in some patients [1][2].

Head-to-head trial data from the SURPASS-2 study showed tirzepatide produced superior weight reduction compared to semaglutide 1mg (approved for diabetes; Wegovy uses 2.4mg for weight management), though direct comparisons at weight-loss doses are still emerging in published literature [4]. Your prescriber will consider your medical history, previous weight loss attempts, tolerance for injection frequency, and cost considerations when recommending the most appropriate treatment.

At Cured Pharmacy, Wegovy starts from £135.00 and Mounjaro from £124.99, allowing you to discuss both options during your free consultation. Some patients begin with one medication and switch to another if they experience tolerability issues or suboptimal response after an adequate trial period, always under prescriber supervision.

Alternative Weight Loss Treatments Available

If injectable medications aren't suitable or preferred, several oral alternatives are available through private prescription. Orlistat (available as branded Xenical or generic formulations) works by blocking fat absorption in the digestive system and may be appropriate for patients with lower BMI thresholds or those who prefer tablet-based treatment.

Cured Pharmacy also offers Saxenda (liraglutide), a daily injectable GLP-1 agonist that predates once-weekly options, and newly available oral semaglutide tablets for patients who prefer not to inject. Your UK prescriber will discuss all clinically appropriate options during your consultation, ensuring you understand the efficacy data, side effect profiles, and cost implications of each treatment pathway.

Understanding the Mounjaro Dose Escalation Schedule

MHRA-approved prescribing guidance for Mounjaro requires a gradual dose escalation protocol to minimise gastrointestinal side effects, which are the most commonly reported adverse events with GLP-1 and dual-agonist medications [1]. Patients typically begin with 2.5mg once weekly for four weeks, then increase to 5mg for four weeks, with further increases to 7.5mg, 10mg, and potentially 15mg at four-week intervals if tolerated and clinically appropriate.

This titration schedule allows your body to adapt to the medication's effects on gastric emptying and appetite signalling, significantly reducing the incidence and severity of nausea, vomiting, and diarrhoea compared to starting at higher doses [3]. Your prescriber may hold you at a lower dose for longer if you experience side effects or achieve satisfactory weight loss at that dose.

Not all patients require the maximum 15mg dose. Clinical trials showed meaningful weight loss across all dose levels, and your prescriber will work with you to identify the minimum effective dose that produces results while maintaining tolerability [2]. This individualised approach often differs from the fixed-dose protocols used in clinical trials.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Mounjaro are gastrointestinal in nature, including nausea (reported by up to 20-30% of patients in clinical trials), diarrhoea, vomiting, constipation, and abdominal discomfort [1][3]. These effects are typically most pronounced during the first few weeks after starting treatment or increasing your dose, and tend to diminish over time as your body adapts.

Practical strategies to minimise gastrointestinal symptoms include eating smaller, more frequent meals rather than large portions, avoiding high-fat and heavily spiced foods, staying well-hydrated, and injecting at consistent times each week. If you experience persistent or severe symptoms, contact your prescriber before your next scheduled dose increase—they may recommend remaining at your current dose for additional weeks.

Rare but serious side effects include pancreatitis (inflammation of the pancreas), gallbladder problems, and hypoglycaemia, particularly in patients taking other diabetes medications [3]. Seek immediate medical attention if you experience severe abdominal pain that doesn't resolve, persistent vomiting, signs of gallstones, or symptoms of low blood sugar such as dizziness, confusion, or rapid heartbeat. Your prescriber will discuss warning signs during your initial consultation.

When to Contact Your Prescriber

Schedule a follow-up consultation with your UK prescriber if you experience side effects that interfere with daily activities, haven't achieved any weight loss after 16 weeks at therapeutic doses, or develop new medical conditions while taking Mounjaro. Regular monitoring ensures your treatment remains safe and effective.

At Cured Pharmacy, ongoing prescriber support is included in your treatment pathway. You can request medication reviews, dose adjustments, or switches to alternative treatments through your secure patient account at any time during your weight management journey.

How to Get a Mounjaro Private Prescription from Cured Pharmacy

Getting started with Mounjaro through Cured Pharmacy takes under three minutes. Begin by completing our online medical questionnaire, which asks about your weight history, previous weight loss attempts, current medications, and relevant medical conditions. This information allows our UK-registered prescribers to assess your suitability for tirzepatide treatment according to MHRA guidelines and clinical best practice.

If approved, your prescription is issued electronically and sent directly to our UK-registered pharmacy (GPhC 9012511) for dispensing. We source all Mounjaro pens from licensed UK wholesalers, ensuring you receive genuine MHRA-approved medication in its original manufacturer packaging. Your order is dispatched in discreet, unmarked packaging with tracking, typically arriving within 1-2 working days to any UK address.

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical services and dispensing operations, ensuring every prescription meets General Pharmaceutical Council standards for safety and accuracy. You'll receive complete injection instructions, storage guidance, and access to ongoing prescriber support throughout your treatment. Repeat prescriptions can be ordered through your patient account when you're ready for your next supply, with the same clinical oversight for every order.

Payment Options and Pricing Transparency

Unlike some providers who reveal costs only after consultation, Cured Pharmacy displays all pricing upfront on our website. The £135.00 starting price for Mounjaro includes your medication, prescriber consultation, and standard UK delivery—no hidden fees or subscription traps. We accept all major credit and debit cards, with secure payment processing and full transaction transparency.

If your prescriber determines Mounjaro isn't clinically appropriate for you during the consultation, you won't be charged. We only process payment when a prescription is issued and your medication is prepared for dispatch, ensuring you pay only for treatments that a qualified UK prescriber has deemed suitable for your individual circumstances.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on glycaemic control and body weight in obesity: the SURMOUNT-1 extension study. The Lancet Diabetes & Endocrinology, 11(5), 313–326. https://doi.org/10.1016/S2213-8587(23)00053-3 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14498 [accessed 13 August 2026]
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro is a prescription-only medication that must be prescribed following a comprehensive medical consultation. Individual results may vary, and weight loss outcomes depend on adherence to lifestyle modifications including reduced-calorie diet and increased physical activity. Always consult a qualified healthcare professional before starting any new medication. If you experience severe side effects or medical emergencies, seek immediate medical attention or call 999.